Finder Award
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Forma Therapeutics is a biotechnology business based in the US. Forma Therapeutics shares (FMTX) are listed on the NASDAQ and all prices are listed in US Dollars. Forma Therapeutics employs 189 staff and has a trailing 12-month revenue of around $7.4 million.
How to buy Forma Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – FMTX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Finder Award
Finder Award
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Forma Therapeutics stock price (NASDAQ: FMTX)
Use our graph to track the performance of FMTX stocks over time.Forma Therapeutics shares at a glance
Information last updated 2023-01-01.
| Latest market close | $0.00 |
|---|---|
| 52-week range | $4.95 - $20.28 |
| 50-day moving average | $17.92 |
| 200-day moving average | $10.90 |
| Wall St. target price | $21.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.82 |
Buy Forma Therapeutics stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 7 of 7
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Forma Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Forma Therapeutics price performance over time
Historical closes compared with the close of $0 from 2022-11-11
| 1 week (2023-03-11) | nan% |
|---|---|
| 1 month (2023-02-18) | nan% |
| 3 months (2022-12-18) | nan% |
| 6 months (2022-09-22) | -100.00% |
| 1 year (2022-03-22) | -100.00% |
|---|---|
| 2 years (2021-03-22) | -100.00% |
| 3 years (2020-03-18) | N/A |
| 5 years (2018-03-18) | N/A |
Forma Therapeutics financials
| Revenue TTM | $7.4 million |
|---|---|
| Gross profit TTM | $-125,661,000 |
| Return on assets TTM | -21.95% |
| Return on equity TTM | -38.27% |
| Profit margin | 0% |
| Book value | $8.67 |
| Market capitalisation | $1 billion |
TTM: trailing 12 months
Forma Therapeutics share dividends
We're not expecting Forma Therapeutics to pay a dividend over the next 12 months.
Forma Therapeutics share price volatility
Over the last 12 months, Forma Therapeutics's shares have ranged in value from as little as $4.95 up to $20.28. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Forma Therapeutics's is -0.9476. This would suggest that Forma Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Forma Therapeutics has bucked the trend.
Forma Therapeutics overview
Forma Therapeutics Holdings, Inc. , a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing Olutasidenib, a selective inhibitor for cancers with isocitrate dehydrogenase 1 gene mutations, which is in Phase II trial for the treatment of relapsed/refractory acute myeloid leukemia and Phase I trial to treat glioma; and FT-8225, a liver-targeted fatty-acid synthase inhibitor designed to block de novo lipogenesis in the liver. Forma Therapeutics Holdings, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts. As of October 14, 2022, Forma Therapeutics Holdings, Inc.
Frequently asked questions
What percentage of Forma Therapeutics is owned by insiders or institutions?Currently 5.131% of Forma Therapeutics shares are held by insiders and 91.072% by institutions. How many people work for Forma Therapeutics?
Latest data suggests 189 work at Forma Therapeutics. When does the fiscal year end for Forma Therapeutics?
Forma Therapeutics's fiscal year ends in December. Where is Forma Therapeutics based?
Forma Therapeutics's address is: 300 North Beacon Street, Watertown, MA, United States, 02472 What is Forma Therapeutics's ISIN number?
Forma Therapeutics's international securities identification number is: US34633R1041
More guides on Finder
-
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Ask an Expert